In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 77 for your search:
Cancer Type/Condition:  Breast cancer, female
Stage/Subtype:  breast cancer in situ
Trial Type:  Treatment
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 40 to 70
Sponsor: NIGMS
Protocol IDs: 0412-14, UO1-GM61373-06, NCT00228956
2.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 50 and over
Sponsor: Other
Protocol IDs: S07-002, 1098558, NCT00882596
3.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 1098987, NCT00882089
4.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 45 and over
Sponsor: Other
Protocol IDs: Mammosite ML, NCT01448447
5.

Phase: Phase IV
Type: Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: P0334, NCT01501487
6.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 40 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CTPR-0009, NCT01644669
7.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Approved-not yet active
Age: 21 and over
Sponsor: NCI
Protocol IDs: URCC-10054, URCC-09005, URCC 10054, NCT01238198
8.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Active
Age: 19 and over
Sponsor: NCI, Other
Protocol IDs: 10-0366-04, NCI-2011-00710, NCT01391689
9.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NSABP-B-39, RTOG-0413, SWOG-NSABP-B-39, NCT00103181
10.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 96/84 Graham, NCT00138814
11.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: TROG 07.01, NHMRC 454390, BIG 3-07, NCIC CTG MA.33, BOOG 2009-03, ICORG 10-06, EORTC 22085-10083, ISCBG 38-10, SCTBG 2009MayPR55, NCT00470236
12.

Phase: Phase III
Type: Diagnostic, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: SU-12102007-930, 98272, BRSNSTU0025, NCT00695916
13.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: NSABP-B-43, NSABP-B-43, NCT00769379
14.

Phase: Phase III
Type: Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 4126, NCT00757302
15.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000636007, INCA-BONBIS, RECF0911, VA-2008/25, ID-RCB-2008-A00494-51, BONBIS, NCT00907868
16.

Phase: Phase III
Type: Diagnostic, Health services research, Treatment
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: IGR IRCIS 1503, NCT01112254
17.

Phase: Phase III
Type: Treatment
Status: Active
Age: 40 and over
Sponsor: Other
Protocol IDs: 2009-APBI, WIRB #20091193, NCT01185132
18.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: RTOG-1005, RTOG-1005, NCT01349322
19.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: S12-01299, NCT01591811
20.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 21 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000573719, P50CA058183, P30CA016672, MDA-P50-CA-58183, BCM-H-19895, 2008-0086, H-19895, BCM-P50-CA-58183, NCT00555152
21.

Phase: Phase II, Phase I
Type: Diagnostic, Treatment
Status: Active
Age: 18 to 90
Sponsor: Other
Protocol IDs: UAMS 07050, NIH Grant 5 R21 CA097715-01, NCT00574301
22.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000644921, UPCC-15107, 807010, NCT00923143
23.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: IFHCC 09-002, NCT01023477
24.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 41 to 90
Sponsor: Other
Protocol IDs: 12-001 Single Fraction IORT, NCT01688388
25.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: UCI 03-16, NCT00256217
1     
New Search